Stocks
MetLife Financial Statements (MET) |
||||||||||
| MetLifesmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 04.05.2023 | 04.08.2023 | 02.11.2023 | 16.02.2024 | 02.05.2024 | 02.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 15 388 | 16 623 | 15 866 | 19 028 | 16 057 | 67 574 | |||
| Operating Income, bln rub | 502.0 | -197.0 | -78.0 | 808.0 | 1 037 | 1 570 | ||||
| EBITDA, bln rub | ? | 507.0 | -197.0 | -78.0 | 808.0 | 1 037 | 1 570 | |||
| Net profit, bln rub | ? | 80.0 | 402.0 | 489.0 | 607.0 | 867.0 | 2 365 | |||
| OCF, bln rub | ? | 2 026 | 3 038 | 3 475 | 5 182 | 2 328 | 14 023 | |||
| CAPEX, bln rub | ? | 0.000 | 774.0 | 423.0 | 383.0 | 0.000 | 1 580 | |||
| FCF, bln rub | ? | 2 026 | 3 812 | 3 898 | 4 799 | 2 328 | 14 837 | |||
| Dividend payout, bln rub | 455.0 | 431.0 | 459.0 | 419.0 | 444.0 | 1 753 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 568.8% | 107.2% | 93.9% | 69.0% | 51.2% | 74.1% | ||||
| OPEX, bln rub | 14 886 | 16 820 | 15 944 | 18 220 | 2 953 | 53 937 | ||||
| Cost of production, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 255.0 | 256.0 | 265.0 | 269.0 | 264.0 | 1 054 | ||||
| Assets, bln rub | 674 266 | 677 279 | 652 120 | 687 584 | 677 576 | 677 576 | ||||
| Net Assets, bln rub | ? | 32 194 | 30 261 | 25 658 | 30 015 | 28 535 | 28 535 | |||
| Debt, bln rub | 17 949 | 17 899 | 18 796 | 18 828 | 19 851 | 19 851 | ||||
| Cash, bln rub | 306 494 | 306 195 | 292 391 | 308 096 | 303 133 | 303 133 | ||||
| Net debt, bln rub | -288 545 | -288 296 | -273 595 | -289 268 | -283 282 | -283 282 | ||||
| Ordinary share price, rub | 57.9 | 56.5 | 62.9 | 66.1 | 74.1 | 60.0 | ||||
| Number of ordinary shares, mln | 775.4 | 765.9 | 751.4 | 730.8 | 723.2 | 723.2 | ||||
| Market cap, bln rub | 44 927 | 43 296 | 47 271 | 48 329 | 53 596 | 43 399 | ||||
| EV, bln rub | ? | -243 618 | -245 000 | -226 324 | -240 939 | -229 686 | -239 883 | |||
| Book value, bln rub | 2 839 | 1 150 | -3 188 | -166 | -344 | -344 | ||||
| EPS, rub | ? | 0.10 | 0.52 | 0.65 | 0.83 | 1.20 | 3.27 | |||
| FCF/share, rub | 2.61 | 4.98 | 5.19 | 6.57 | 3.22 | 20.5 | ||||
| BV/share, rub | 3.66 | 1.50 | -4.24 | -0.23 | -0.48 | -0.48 | ||||
| EBITDA margin, % | ? | 3.29% | -1.19% | -0.49% | 4.25% | 6.46% | 2.32% | |||
| Net margin, % | ? | 0.52% | 2.42% | 3.08% | 3.19% | 5.40% | 3.50% | |||
| FCF yield, % | ? | 29.6% | 29.2% | 26.0% | 30.1% | 27.7% | 34.2% | |||
| ROE, % | ? | 6.06% | 7.34% | 9.02% | 5.26% | 8.29% | 8.29% | |||
| ROA, % | ? | 0.29% | 0.33% | 0.35% | 0.23% | 0.35% | 0.35% | |||
| P/E | ? | 23.0 | 19.5 | 20.4 | 30.6 | 22.7 | 18.4 | |||
| P/FCF | 3.38 | 3.42 | 3.85 | 3.33 | 3.61 | 2.93 | ||||
| P/S | ? | 0.65 | 0.61 | 0.74 | 0.72 | 0.79 | 0.64 | |||
| P/BV | ? | 15.8 | 37.6 | -14.8 | -291.1 | -155.8 | -126.2 | |||
| EV/EBITDA | ? | -74.1 | -85.3 | -102.7 | -231.7 | -146.3 | -152.8 | |||
| Debt/EBITDA | -87.8 | -100.4 | -124.1 | -278.1 | -180.4 | -180.4 | ||||
| R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0 | ||||||
| CAPEX/Revenue, % | 0.00% | 4.66% | 2.67% | 2.01% | 0.00% | 2.34% | ||||
| MetLife shareholders | ||||||||||
